BNP Paribas FTSE EPRA Eurozone THEAM Easy UCITS ETF C (EEA) Quote

Amen. It took MK a year to write up and submit rabbit data. Even if he gets positive data out of India by mid year, it's hard to see him submitting IDE this year now that he's confirmed submission depends on India results. It is what it is. Gotta feel bad for the moron who bought portion of curr

The global helium market is experiencing strong growth, projected to expand at a CAGR of 8.3% from 2024 to 2030, reaching an estimated value of USD 27.06 billion. This surge is driven by increasing demand across key sectors such as electronics, semiconductors, and medical imaging, as well as aerospa

It sounds like they just need more data, so it will just take a little longer, simple as that.

I hear ya Mikey. I had schwab and td when they merged. Prefer td. If it wasn't such a pain to switch id go fidelity.

Take care...

So, a post that includes facts and an outcome to the sec that differs from the majority of people that feel it could be the opposite outcome is "utter nonsense?"

Got it. Baaa baaa

Well... I suppose Trump wouldn't mind if people died in the streets. He could just go to one of his clubs until the fuss died down.

You know the asteroid that'll come very close to earth in 2032? It needs to be named after Trump. Right now.

Every single news piece reads like an Orwellian novel. the speed at which trump has attacked all constitutional safeguards is astonishing. The more striking part about this is how so many city/states are participating and helping the cause for complete dismantling of all norms. Trump is about to

Stock is worth $2.00 plus now,when deal is done it will be worth $4.00 cash alone with no debt.At that point it will be worth $8 to $10 bucks.This has a lot more to go.M&M are holding this down to get in,then this will fly.Good luck and good trading.

I didn't see the fda turning this down.  Did I miss something?  Questions have been answered and now they can submit.  What am I missing?

I agree that ultimately our share price should be based on our P/E and anticipation of growth. If the growth is as great as I believe, a P/E over 30 is very possible. I'm basing that on DCVax-L being determined to be tumor agnostic and it's use growing into many of the deadliest cancers.

I am waiting until earnings. Could be one hell of a buying opportunity.

An awful long post just to say nothing..

You go girl…

All cancer? 20 million cases worldwide per year. Say you get 3% that uses the vaccine. That is 600K patients. 

600,000 X  $100,000 per patient is $60 Billion in revenue.

Say high margins of 50% is 30 Billion 

$30 Billion / 1.7 billion shares is $17.6

Does not even resemble an ok q report it is so bad

Defendants Lack Standing to Argue This Action Must Be Derivative

The Faro Defendants, as individuals, lack standing to argue that Plaintiff’s claims must be asserted derivatively. Standing to challenge whether a claim is derivative or direct rests with the corporation itself. Where a

Defendants Lack Standing to Argue This Action Must Be Derivative

The Faro Defendants, as individuals, lack standing to argue that Plaintiff’s claims must be asserted derivatively. Standing to challenge whether a claim is derivative or direct rests with the corporation itself. Where a

Lol

Then why the need for the $0.08 .0004 sell???

Weird huh??

I understand the topic can be complex. Please reach out to me if you need anything further explained!

He is sort of right except there are no checks anymore. SSI gets a bad name since it is for people who never worked and have no SS benefits. So the government pays them a supplemental income; SSI to keep them from dying in the streets.

nclh news after the bell...... LOL More insider selling.

3 more days for $SMCI to file.

If they don't file, then the share price could drop down to the teens.

I'm not sure how Q4 will go. Sales were brisk YoY and revs are starting to show for swap. I guess it's all in the margins. Not sure if I should add at low 4's or wait until earnings come out.

I'm not quite 100% on my NIO position yet.